Printer Friendly
The Free Library
21,446,310 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Anti-HIV agents topic

 

Articles

1-300 out of 500 article(s) nextnext page
Title Author Type Date Words
Strategic consulting, design and implementation of an information and awareness campaign for the recruitment of participants in anti-HIV vaccine trials conducted by the Vaccine Research Institute. May 15, 2013 101
Risk of nevirapine-associated Stevens-Johnson syndrome among HIV-infected pregnant women: the Medunsa National Pharmacovigilance Centre, 2007-2012. Dube, N.; Adewusi, E.; Summers, R. May 1, 2013 3089
Anti-HIV therapy appears to protect children's hearts, NIH network study shows. Apr 22, 2013 107
Frost & Sullivan: New Drug Candidates Hold Tremendous Promise for European HIV Drugs Market. Apr 17, 2013 721
Frost & Sullivan: New Drug Candidates Hold Tremendous Promise for European HIV Drugs Market. Apr 17, 2013 726
Critical AIDS medications: to Africa for the US Government. Larson, Chris Apr 1, 2013 1704
Funding For AIDS Drugs Not Included In Senate Spending Bill. Mar 19, 2013 555
Doctors in the US cure baby of HIV. Mar 7, 2013 420
Doctors in the US cure baby of HIV. Mar 5, 2013 420
AHF Demands FDA Reversal on Use of Gilead's HIV Prevention Pill for Women. Mar 5, 2013 604
Doctors in the US cure baby of HIV. Mar 4, 2013 420
Research and Markets: Nevirapine - Comprehensive 2013 Patent Search. Feb 18, 2013 441
AHF Challenges Gilead over AIDS Drug Price Gouging of U.S. Gov't Programs on 'Stribild'. Jan 30, 2013 600
Study on Generic HIV Meds Prompts AHF to Demand Gilead Cut ARV Prices. Jan 16, 2013 685
AHF Blasts Gilead Price Hike on Four Key AIDS Drugs. Jan 10, 2013 838
Event 300mg tablet tenofovir 38-2012. In response to amparo 01020-2010-00042. Jan 10, 2013 108
AIDS drugs cut SA's maternal death rate. Bateman, Chris Jan 1, 2013 376
HIV drug 'may help defuse deadly staph infections'. Dec 15, 2012 633
Nigeria : MSD offers a new treatment for HIV in NIGERIA. Dec 6, 2012 237
AHF: Corporate Welfare Spurs Gilead's Record Profits on AIDS Drugs. Dec 4, 2012 643
Nevirapine for PMTCT in immuno-competent pregnant women--a warning. Seggie, Janet Brief article Nov 1, 2012 103
Safety of nevirapine in HIV-infected pregnant women initiating antiretroviral therapy at higher CD4 counts: A systematic review and meta-analysis. Bera, Ebrahim; Mia, Rafiq Report Nov 1, 2012 4701
AHF: Gilead Scores Record Profits on AIDS Drug Price Gouging. Financial report Oct 25, 2012 677
Cruel Joke: AIDS-Plagued Tanzania Must Also Cope With Fake HIV Drugs. Oct 12, 2012 614
Neutron Crystallography Aids Drug Design. Oct 9, 2012 599
AHF: Texas and Louisiana Medicaid Not Yet Covering Gilead's Pricey AIDS Drug, Stribild. Oct 8, 2012 1136
HIV Drug Efavirenz May Cause Memory Decline. Sep 29, 2012 347
Common HIV drug may damage brain and lead to memory decline. Sep 28, 2012 613
AHF: Gilead's Stribild Not Covered by NY Medicaid; State Also Explores 'Prior Auth' Status for AIDS Drug. Sep 24, 2012 756
Research and Markets: Global HIV Drug Pipeline Capsule - 2012 Update. Sep 19, 2012 293
AHF: Gilead Must Offer ADAP AIDS Drug Price Cut to Medicaid, Medicare. Sep 18, 2012 1123
HIV treatment-naive option okayed. Sep 15, 2012 116
United States : New Common Application for HIV/AIDS Medicines Available Through Johnson & Johnson Patient Assistance Foundation, Inc. Sep 13, 2012 383
New Common Application for HIV/AIDS Medicines Available Through Johnson & Johnson Patient Assistance Foundation, Inc. Sep 12, 2012 548
Anti-HIV vaginal ring can prevent virus transmission. Sep 6, 2012 472
AHF Supports Price Cut on New AIDS Drug, Prods Gilead to Expand Cut to Other Programs. Sep 6, 2012 994
New computer model offers 'realistic' tool to predict HIV drug resistance. Sep 3, 2012 415
Protease inhibitors and stomach acid drugs linked to fractures in HIV+ veterans. Sep 1, 2012 1443
Research and Markets: Lopinavir - Comprehensive Patent Search. Aug 31, 2012 446
United States : FDA approves new combination pill for HIV treatment for some patients. Aug 28, 2012 414
AHF: As Gilead Prepares to Price the 'Quad,' 20 California Legislators Say Aids Drug Pricing "Unsustainable". Aug 18, 2012 996
AHF Lauds Rep. Alcee Hastings (D, FL) for Congressional Letter Cautioning Gilead on Pricing of New AIDS Drug. Aug 14, 2012 1483
Ranbaxy, Gilead Sciences ink in-licensing pact to promote access to less costly HIV drugs. Aug 3, 2012 315
SA patent law blocking vital second-line HIV drugs. Bateman, Chris Aug 1, 2012 354
Truvada approved for HIV prevention. Aug 1, 2012 333
United States : MERCK inks two licensing agreements for HIV drug candidates. Jul 27, 2012 155
Gilead's Boosting Agent Cobicistat for HIV Therapy as Effective as Ritonavir in Pivotal Phase 3 Study. Clinical report Jul 24, 2012 1639
Anti-HIV drugs 'may pass to baby in womb and during breast-feeding'. Jul 22, 2012 682
HarborPath Creates a Single Portal for Uninsured Individuals to Access HIV/AIDS Medications. Jul 19, 2012 1207
Obama Administration Touts Delayed Release of AIDS Drug Funds, Says AHF. Jul 19, 2012 452
Research and Markets: Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth. Jul 12, 2012 366
AHF: Gilead's "Me Too" Quad AIDS Drug Offers Little Improvement, More Kidney Damage. Jul 6, 2012 1276
AHF: CA State Treasurer Lockyer Urges Gilead to Show Restraint Pricing New AIDS Drug the 'Quad'. Jun 27, 2012 930
Adding nevirapine to HIV regimen halves newborn transmission rate. Brief article Jun 21, 2012 105
Ohio: AIDS Patients Win Another Round against State's Illegal Restrictions on AIDS Drug Access, Says AHF. Jun 12, 2012 1163
AIDS Advocates to Gilead: Save More Lives, Price the "Quad" Reasonably. Jun 11, 2012 1199
Enamine, MRC LMB and IOCB Announce Collaboration to Identify Novel Rhomboid Protease Inhibitors for Treatment of Various Diseases. Jun 6, 2012 506
One Year Post-Launch, The Protease Inhibitors, Incivek and Victrelis have Collectively Penetrated Over Three-Quarters of the US Genotype 1 HCV Market. Jun 6, 2012 786
Approaches to tenofovir and abacavir drug shortages in South Africa: a guide for clinicians. Schowalter, Laurie; Conradie, Francesca Jun 1, 2012 816
Mylan Launches Generic Version of Viramune Tablets. May 23, 2012 468
Since Gaining European Authority Approval for Victrelis in July and Incivo in September, Protease Inhibitor Share Has Penetrated Nearly One-Third of the Genotype 1 Market and is Anticipated to Significantly Increase Over the Next Six Months. May 21, 2012 690
Anti-HIV drug tenofovir 'safe to take during pregnancy'. Medical condition overview May 16, 2012 428
Research and Markets: Hepatitis C Virus - Protease Inhibitors Bring Change in the Treatment Paradigm for Hepatitis C Virus Infection - What Next? May 3, 2012 375
Anti-HIV drug use during pregnancy does not affect infant size, birth weight. May 1, 2012 124
AHF: AIDS Patients Protest, Testify Against Ohio Plan to Ration AIDS Drugs. Apr 5, 2012 1112
Why it's time to say goodbye to stavudine ... everywhere. Andrieux-Meyer, Isabelle; Clayden, Polly; Collins, Simon; Geffen, Nathan; Goemaere, Eric; Harrington Report Mar 1, 2012 2876
Low-dose stavudine trials: a public health priority for developing countries. Venter, W.D. Francois; Innes, Steve; Cotton, Mark Report Mar 1, 2012 2153
Safety, strength and simplicity of efavirenz in pregnancy. Pillay, Prinitha; Black, Vivian Report Mar 1, 2012 6047
AHF Challenges FDA Move to Fast Track Gilead's 'HIV Prevention' Drug Linked to Kidney Disease. Feb 16, 2012 680
Research and Markets: Global HIV Drugs Market 2010-2014 Report - The Global HIV Drugs Market to Reach US$15.5 Billion By 2014. Feb 14, 2012 404
Nevirapine and co-trimoxazole prophylaxis safe in HIV-exposed, uninfected infants. Feb 1, 2012 1017
Vitamin D may improve bone health in those taking anti-HIV drug. Brief article Jan 10, 2012 104
Research and Markets: Global HIV Drug Pipeline Capsule 2012: highlighting key research and development activities across the globe. Jan 10, 2012 390
SQU team to study genetic factors in AIDS treatment. Jan 2, 2012 873
Raltegravir-based HIV therapy bests efavirenz. Mahoney, Diana Jan 1, 2012 599
Merck and the ADAP Crisis Task Force Announce New Agreement to Improve Access and Care for People with HIV. Dec 21, 2011 2131
FDA Expands Use of HIV Drug Isentress to Children and Adolescents. Dec 21, 2011 717
AHF Salutes Merck for AIDS Drug Price Cuts for Hard-Hit Programs. Dec 21, 2011 983
AHF Slams Gilead "HIV Prevention Pill" FDA Application. Dec 16, 2011 1097
AHF Targets Merck Over AIDS Drug Pricing. Dec 8, 2011 670
AHF Praises J&J for AIDS Drug Price Cut, Asks Merck to Follow Suit. Dec 8, 2011 672
AHF Salutes Gilead on Price Cuts for US AIDS Drug Program. Dec 5, 2011 1077
Why should we still care about the stavudine dose? Innes, Steve; Cotton, Mark; Venter, Francois Viewpoint essay Dec 1, 2011 1519
AHF to Stage "Occupy Gilead" Protest Over Gilead's AIDS Drug Prices. Nov 30, 2011 1286
Vioxx: Merck Continues Bad Behavior With AIDS Drug Pricing, Says AHF. Nov 23, 2011 546
Research and Markets: The HIV Drugs Market in India to Reach US$54 Million by 2014 According To Recent Report. Nov 21, 2011 385
UN Reports Death and Infections Down Due to AIDS Drugs - Funding Must Go Up, Says AHF. Nov 21, 2011 595
AHF to Stage "Day of the Dead" Funeral Procession to Protest Gilead's AIDS Drug Prices. Nov 2, 2011 1544
HIV testing update. Cohen, Jenny K.; Klausner, Jeffrey D. Report Nov 1, 2011 5418
Over the Next Decade, the Dominance of Bristol-Myers Squibb/Gilead's Atripla in the HIV Drug Market Will Be Challenged by Gilead's Quad and Gilead/Janssen's Complera. Oct 27, 2011 629
NIH researchers show how anti-HIV drug acts to block herpes virus. Brief article Oct 20, 2011 105
Merck's ISENTRESS[R] (raltegravir) in Combination Therapy Demonstrated Virological and Immunological Efficacy Versus the Efavirenz Regimen at 192 Weeks of Treatment in Previously Untreated Adults with HIV-1. Oct 13, 2011 5798
AHF: Global Fund Rejects Request To End U.S. AIDS Drug Crisis. Oct 13, 2011 509
Hepatitis C Landscape is Changing as the New Protease Inhibitors are Adopted into Clinical Practice. Oct 6, 2011 736
Over 380,000 Malawians on free HIV drugs: officials. Oct 5, 2011 183
AHF Hosts NJ Protest & 'Die-In' over J&J's AIDS Drug Prices--September 30th. Sep 30, 2011 1242
AHF Sues FDA over Information on Gilead's HIV Prevention Pill. Sep 23, 2011 972
AHF Requests $50M Help from Global Fund, Warren Buffett to End AIDS Drug Crisis in US. Sep 15, 2011 1682
Open Letter From HIV-Positive Prevention Advocates Rejects Misinformation About Pre-Exposure Prophylaxis (PrEP). Sep 15, 2011 948
AHF Hosts Third "Die-in" Protest Over Gilead's AIDS Drug Prices. Sep 13, 2011 1457
AIDS Advocates to J & J: 'AIDS Drug Prices to Die For!'; Sept. 9th Protest, New Brunswick, NJ--12:30pm. Sep 9, 2011 1163
AHF Spearheads 'Pill Bottle Protest' Over Gilead's AIDS Drug Prices. Aug 31, 2011 1040
Gilead PrEP Campaign Leads to Truvada Black Market in Florida, AHF Says. Aug 19, 2011 935
AHF Stages Second "Die-in" & Protest Over Gilead's AIDS Drug Prices. Aug 18, 2011 818
AHF Hosts NJ Protest & 'Die-In' Over J&J's AIDS Drug Prices--August 17th Noon. Aug 16, 2011 1328
SOUTH AFRICA : South Africa to offer better provision of anti-AIDS drugs. Aug 16, 2011 230
NanoViricides Reports HIVCide Exhibited Long Term Sustained Anti-HIV Effects Even After Drug Discontinuation. Aug 15, 2011 1308
Why some HIV cocktails pack a bigger punch: steep dose-response curves explain drugs' characteristics. Ehrenberg, Rachel Aug 13, 2011 765
AHF: Gilead's Pricing of Complera May Break Hard-Hit AIDS Drug Programs. Aug 11, 2011 860
AHF: Sen. Rubio (R, FL) Offers Obama Administration Proposal to End Growing AIDS Drug Crisis. Aug 8, 2011 858
AHF Hosts Protest & "Die-in" Over Gilead's AIDS Drug Prices. Aug 3, 2011 1523
AHF: Victory! Boehringer Ingelheim to Increase AIDS Drug Program Rebates. Aug 3, 2011 670
AHF: AIDS Protesters to Merck: 'Do the Right Thing!' on Drug Prices -- NJ Protest, July 28th. Jul 27, 2011 1763
AHF: AIDS Protesters to J & J: 'No More Tears!' on AIDS Drug Pricing--July 27th NJ Protest. Jul 26, 2011 1564
NanoViricides Reports Anti-HIV Efficacy Equivalent to HAART Drug Cocktail Treatment in Animal Study, Successfully Advancing its HIVCide Lead Optimization Program. Report Jul 25, 2011 1477
Obama Administration Decision May Force Florida to Pull AIDS Medications from Existing Patients. Jul 25, 2011 536
In the Real Life Setting, Boosted REYATAZ (atazanavir/ritonavir) Proves as Effective in Women Living with HIV as Men. Clinical report Jul 20, 2011 1172
VICTRELIS[TM] (boceprevir), First-in-Class Oral Hepatitis C Virus Protease Inhibitor, Approved in the European Union for Treatment of Chronic Hepatitis C. Jul 18, 2011 2148
Ranbaxy,Gilead Sciences to manufacture and market three anti-HIV drugs in India, developing nations. Jul 14, 2011 339
AHF to Protest Bay Area's Gilead Sciences over AIDS Drug Pricing at SF's Fed Building. Jul 13, 2011 1363
HIV Drugs Reduce Transmission Risk for Heterosexual Couples. Jul 13, 2011 520
Anti-HIV Drugs Prevent Infection in Healthy Heterosexuals, An End to the HIV Epidemic? Jul 13, 2011 317
AHF Lauds Gilead as First to Share AIDS Drug Patents with New Global Patent Pool. Jul 12, 2011 507
Doctors to FDA: "HIV Prevention Pill" Not Ready for Approval. Jun 29, 2011 1155
AHF Challenges Gilead over AIDS Drug Pricing During Protest at Foster City HQ. Jun 29, 2011 880
Atlanta TONIGHT: Rep. John Lewis to Appear at AIDS Drug Crisis Town Hall. Jun 28, 2011 1130
HIV drugs linked to premature aging. Jun 27, 2011 118
AIDS Advocates to Rally at Ohio Statehouse Over AIDS Drug Crisis. Jun 13, 2011 869
Massive Opportunity Exists in Hepatitis C Market for Recently Approved Protease Inhibitors Victrelis and Incivek According to a New Report by BioTrends Research Group. Jun 13, 2011 555
AHF Slams Feds for Pressing Florida to Cut Eligibility for Lifesaving AIDS Drug Program. Jun 10, 2011 986
Underutilization of the AIDS drug assistance program: associated factors and policy implications. Godwin, Noah C.; Willig, James H.; Nevin, Christa R.; Lin, Hui-Yi; Allison, Jeroan; Gaddis, Kathy; P Clinical report Jun 1, 2011 4867
Research and Markets: HIV - Better Differential Pricing Strategies are Needed to Ensure Access to HIV Drugs. Jun 1, 2011 376
Longer anti-HIV therapy is worth the cost. Rosenberg, Jared Jun 1, 2011 408
Research and Markets: Telaprevir and Boceprevir: The First Generation Protease Inhibitors Boosts Response Rates to Standard Chronic Hepatitis C Treatment. May 31, 2011 328
FDA Approves New HIV Treatment. May 20, 2011 727
Protease inhibitors poised to improve HCV outcomes. Mechcatie, Elizabeth May 15, 2011 554
FDA Approves Merck's VICTRELIS(TM) (boceprevir), First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor. May 14, 2011 4124
FDA Approves Merck's VICTRELIS[TM] (boceprevir), First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor. May 13, 2011 4039
Traces of Fungicide Found in HIV Drug. May 12, 2011 365
HIV drugs can also kill malaria parasites: Study. May 3, 2011 166
AHF's Board Opposes FDA-approval of Gilead's AIDS Drug Truvada as HIV Prevention. May 3, 2011 855
Prevalence of drug-resistant mutations in newly diagnosed drug-naive HIV-1-infected individuals in a treatment site in the Waterberg district, Limpopo province. Nwobegahay, Julius; Bessong, Pascal; Masebe, Tracy; Mavhandu, Lufuno; Manhaeve, Cecile; Ndjeka, Norb Report May 1, 2011 2070
Post-natal ARV prophylaxis for infants: efficacy of extended nevirapine. Brief article May 1, 2011 272
AHF to Question Abbott on AIDS Drug Pricing During April 29 AGM in Abbott Park. Apr 29, 2011 787
AHF: Gilead Must Halt FDA Approval of Truvada as HIV Prevention After PrEP Study in Women Fails. Apr 18, 2011 875
CA Treasurer Seeks AIDS Drug Price Cuts from Gilead, Others. Apr 11, 2011 1038
FDA Approves One-Pill, Once-Daily Viramune XR(TM) (nevirapine) Extended-Release Tablets for Use in Combination With Other Antiretroviral Agents for Treatment of HIV-1 Infection in Adults. Apr 4, 2011 2070
The risks of concurrent treatment with tenofovir and aminoglycosides in patients with HIV-associated tuberculosis. Kenyon, Chris; Wearne, Nicci; Burton, Rosie; Meintjes, Graeme Case study Apr 1, 2011 2385
PHPT-3 trial. Report Apr 1, 2011 520
AHF: CA Controller Chiang Urges AIDS Drug Price Cut from Merck, Tibotec & ViiV. Mar 31, 2011 1009
AHF: CA Controller Chiang Urges AIDS Drug Price Cut from Abbott, BI, BMS & Genentech. Mar 30, 2011 1032
ActiveSite Pharmaceuticals' Small Molecule Protease Inhibitor Blocks Retinal Blood Vessel Damage in Rodent Model of Diabetes. Mar 28, 2011 505
AHF: CA Controller Chiang Urges Gilead to Cut AIDS Drug Prices. Mar 25, 2011 991
Testing, linking, retaining: an HIV clinician's perspective: an interview with Michael J. Mugavero, MD. Mascolini Interview Mar 22, 2011 4001
Twenty years' working in HIV nursing: a personal journey. Bellingham, Catriona Essay Mar 22, 2011 2766
AHF to Gilead: "No Magic Pill" Ads Warn against AIDS Drug as HIV Prevention. Mar 9, 2011 1910
New HIV/AIDS study could turn treatment 'on its head'. Mar 5, 2011 502
New drug regimens cut HIV spread from mother to infant. Mar 2, 2011 135
AHF: Representative Hastings (D, FL) Ups AIDS Drug Budget by $42M. Feb 19, 2011 1322
AHF: Obama FY12 Budget Continues Rationing on AIDS Drugs. Feb 18, 2011 954
FDA Approves Labeling Update for REYATAZ[R] (atazanavir sulfate) Capsules to Include Data Supporting the Recommended Adult Dose of REYATAZ/ritonavir 300/100 mg for HIV-1 Infected Pregnant Women. Feb 7, 2011 2680
AHF Seeks 20% Price Cut from AIDS Drug Companies for State Program. Feb 3, 2011 1105
AHF Offers Alternatives to Rationing AIDS Drugs. Jan 20, 2011 1016
AIDS Drug Maker Boehringer Ingelheim Refuses to Increase Access for Low-Income Patients. Jan 19, 2011 1068
AHF: Florida Plan to Limit AIDS Drug Access Halted. Jan 7, 2011 1181
Boceprevir, Merck's Investigational Oral Hepatitis C Protease Inhibitor, Receives FDA Priority Review and EMA Accelerated Assessment. Jan 6, 2011 767
AHF Will Supply $1 Million in Free AIDS Drugs to Florida Wait List Patients. Jan 3, 2011 996
Press Telecon: AHF Sues AIDS Drug Maker Johnson & Johnson/Tibotec Therapeutics for Overcharging. Dec 21, 2010 1160
HIV drugs offer barrier to virus: antiretrovirals limit infection rate among men at high risk. Seppa, Nathan Dec 18, 2010 330
Dec. 20th, Miami Town Hall: AIDS Advocates to Call on Sen. Nelson to Solve FL AIDS Drug Crisis. Dec 17, 2010 1525
Researchers Find How HIV Eludes Treatment. Dec 16, 2010 321
US Hoards $48B in Unobligated Health Funds as AIDS Drug Crisis Threatens Lives of Over 4,500 Americans, Says AHF. Dec 16, 2010 785
How 'chameleon-like' HIV virus eludes treatment by mutating. Dec 16, 2010 230
Australian Market Report of December 8, 2010: Aston Resources (ASX:AZT) and ITOCHU (TYO:8001) To Establish Maules Creek Coal Joint Venture. Dec 8, 2010 361
Save Florida AIDS Patients! Save ADAP! Nov 30th Ft. Lauderdale Rally Targets Crisis in Florida's AIDS Drug Program. Nov 29, 2010 1213
Zacks Analyst Blog Highlights: Gilead Sciences, Johnson & Johnson, Bristol-Myers Squibb, Parker Hannifin Corporation and Eaton Corporation. Nov 26, 2010 1200
South Africa's 'Whoonga' craze: mixing HIV drugs with marijuana. Nov 23, 2010 248
HIV drugs 'lead to insulin resistance'. Nov 23, 2010 229
Study Finds New Target for HIV Drug Therapies. Nov 22, 2010 636
Fight to give HIV drugs to newborn; COURTS 1. Nov 20, 2010 123
New Long-Term Observational Study Shows Durable Viral Suppression of Boosted REYATAZ(R) (atazanavir/ritonavir)-Based Regimens in a Real-Life Setting in Treatment-Experienced HIV Patients. Clinical report Nov 9, 2010 572
AHF Blasts Florida's 'Scorched Earth' Approach to AIDS Drug Crisis: State Abandons 350 Patients. Nov 3, 2010 1131
Glaxo subpoenaed regarding Avandia, HIV drugs. Brief article Nov 2, 2010 284
Developing Canada's research base for harm reduction and health equity approaches to HIV prevention and treatment. Shoveller, Jeannie; DeBeck, Kora; Montaner, Julio Report Nov 1, 2010 2637
Owing Largely to the Generic Erosion of Key Antiretroviral Agents, Growth in the HIV Drug Market Will Decline to 2.2 Percent Annually From 2014 to 2019. Oct 27, 2010 741
New Label Changes for Commonly Prescribed HIV Drug Invirase. Oct 21, 2010 650
Silver lining seen in failed trial of anti-HIV gel. Smith, Jennie Oct 15, 2010 654
HIV drug treatment doesn't reduce risk of partner infection. Oct 1, 2010 343
Wednesday, Sept. 29th: AIDS Advocates to Protest Speaker Pelosi's Silence on AIDS Drug Crisis. Sep 28, 2010 1391
Biomedical approaches to HIV prevention. Mayer, Kenneth H.; Skeer, Margie; Mimiaga, Matthew J. Report Sep 22, 2010 7385
No gender-based difference in HIV treatment response. Sep 21, 2010 482
How HIV resists AIDS preventing AZT drug. Sep 20, 2010 294
Docs breach norms to prescribe costly AIDS drugs. Sep 15, 2010 450
Four US medical workers arrested in Zimbabwe over AIDS drugs. Sep 12, 2010 310
In utero tenofovir linked to low weight at 1 year. Zoler, Mitchel L. Sep 1, 2010 550
FL: suit for breach of confidentiality dismissed: Dr. asks about HIV meds in childrens' presence. Tammelleo, A. David Case overview Sep 1, 2010 477
AHF Offers Solution to End Florida's AIDS Drug Waiting List. Sep 1, 2010 1306
A rare phenomenon of atypical lipodystrophy in a patient on HAART in the absence of a protease inhibitor regimen. Mitha, Mohammed; Cupido, Gordon; Taljaard, Jantjie Case study Sep 1, 2010 920
Shift to generic HIV drugs increased access, saved money. Rosenberg, Jared Author abstract Sep 1, 2010 261
Early start of HIV drug treatment saves lives. Rosenberg, Jared Report Sep 1, 2010 250
FL Sen. Bill Nelson Tells Senate Leadership More Money Is Needed for Hard-hit AIDS Drug Program, Reports AHF. Aug 20, 2010 1191
New approach for targeted killing of HIV virus. Aug 19, 2010 312
Promising new HIV drug keeps virus out of cells. Aug 19, 2010 390
Bristol-Myers Squibb and ADAP Crisis Task Force Announce Enhanced, Multi-year Support for AIDS Drug Assistance Programs (ADAPs) in the United States. Aug 11, 2010 1046
BMS Yields on AIDS Drug Pricing Following Sustained AHF Advocacy Campaign, Says AHF. Aug 11, 2010 1553
BMS to Yield on AIDS Drug Pricing following Sustained AHF Advocacy Campaign, Says AHF. Aug 5, 2010 1351
NJ Avoids Deadly AIDS Drug Cuts While Local Drug Giant BMS Refuses to Cut Prices for ADAPs, Says AHF. Aug 3, 2010 744
Experimental tenofovir vaginal gel stops HIV infection. Zoler, Mitchel L. Clinical report Aug 1, 2010 701
CA Controller Chiang Urges BMS to Cut Price of AIDS Drug Reyataz, says AHF. Jul 27, 2010 999
A vaginal gel containing Gilead Sciences Inc's (Foster City CA) AIDS drug Viread cut HIV infections by as much as 54% in a trial in South Africa, the first time such a product has protected women after six previous gels failed. Jul 26, 2010 385
NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB. Jul 22, 2010 189
Study Shows Once-Daily, Extended-Release Formulation of Nevirapine was not Inferior to Twice-Daily VIRAMUNE in Treatment-Naive HIV-1 Infected Patients. Jul 22, 2010 1521
TOMORROW -- AIDS Advocates to Rally at Iowa Capitol Bldg. Over AIDS Drug Crisis. Jul 19, 2010 815
AIDS gel medicine helps reduce infections. Jul 19, 2010 309
Anti-AIDS gel helps prevent infection, study finds. Jul 19, 2010 501
Photo of AHF-Led AIDS Drug Protest in Ft. Lauderdale Available on Business Wire's Web Site and AP PhotoExpress. Jul 16, 2010 164
TOMORROW: AIDS Advocates to Protest at Federal Bldg to Save AIDS Drug Program. Jul 15, 2010 1356
Statement from Secretary Sebelius on Reallocating $25 Million for AIDS Drug Assistance. Jul 9, 2010 348
AHF Pops Obama Trial Balloon of $30M for Hard-Hit US AIDS Drug Assistance Program. Jun 25, 2010 350
AIDS drugs block 99pc of HIV transmission to breastfed babies. Jun 17, 2010 203
Idenix Pharmaceuticals Initiates Proof-of-Concept Study for Protease Inhibitor IDX320 in Hepatitis C Patients. Jun 10, 2010 1286
NanoViricides Reports that Antiviral Efficacy was Demonstrated Against Two Different HIV-1 Isolates in Cell Culture Studies, Corroborating Previous Findings in Animal Studies. Jun 8, 2010 1063
Gilead Sciences and ADAP Crisis Task Force Announce New Initiatives to Support AIDS Drug Assistance Programs (ADAPs). Jun 4, 2010 1232
AHF Lauds Gilead for AIDS Drug Price Concessions for Nation's ADAPs. Jun 4, 2010 557
AHF Advocacy Spurs AIDS Drug Companies to Yield on Pricing. Jun 3, 2010 1216
HIV Tests Can Do More Harm Than Good. Jun 2, 2010 400
Research and Markets: HIV Drugs - Global Strategic Business Report: Annual Estimates and Forecasts Are Provided for the Period 2006 Through 2015. Report May 25, 2010 337
AHF to Obama: Solve US AIDS Drug Crisis Now. May 25, 2010 479
Senate Bill by Coburn & Burr Takes Aim at AIDS Drug Crisis, Says AHF. May 24, 2010 366
Vaginal gel could offer protection against HIV. May 24, 2010 455
Gout treatment gets label update for HIV drug interaction. May 18, 2010 336
NanoViricides Signs anti-HIV Drug Candidate Testing Agreement with University of California, San Francisco. May 17, 2010 812
New, inexpensive pouch could reduce mother-to-infant HIV infection. May 15, 2010 278
NYC Protest: AHF to Blast BMS on AIDS Drug Pricing at Bank of America Healthcare Conference. Conference news May 11, 2010 942
Heinz Family Philanthropies, Welvista and Abbott Announce Solution to Help Patients on State ADAP Waiting Lists for No-Cost HIV Medications. May 7, 2010 878
FDA Recommends New Dosing for Colcrys(R) (Colchicine, USP) when Co-Administered with Protease Inhibitors. May 6, 2010 1455
AHF: Giant CA Pension Fund Expresses Concern about BMS' Pricing on Key AIDS Drug Reyataz. May 4, 2010 753
AIDS Drug Company Price Cuts Validated By New Data, Says AHF. May 4, 2010 712
Protease-inhibitor interactions--a structural insight. Laskar, Aparna; Mandal, C.N.; Chatterjee, Aniruddha May 1, 2010 8680
Dysfunctional MCC under legal threat. Bateman, Chris May 1, 2010 1286
HAART during pregnancy and breastfeeding in the developing world. May 1, 2010 491
Pregnancy associated with hepatotoxicity regardless of nevirapine exposure, USA. Brief article May 1, 2010 198
Research and Markets: HIV/AIDS - Drug Pipeline Analysis and Market Forecasts to 2016. Apr 28, 2010 508
Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra (R) (lopinavir / ritonavir) for Treatment-Experienced Patients. Apr 28, 2010 2038
Victory! AHF Lauds Merck for Doubling ADAP AIDS Drug Rebates for Isentress. Apr 27, 2010 1294
AIDS Drug Access Bill Clears Key Florida Legislative Committee, Notes AHF. Apr 12, 2010 1249
AHF Presses BMS to Slash Price of Key AIDS Drug Reyataz. Apr 6, 2010 638
Expected surge in HIV drug resistance. Currie, Donya Apr 1, 2010 204
HIV drug pipeline diverting more agents to first-line use. Boschert, Sherry Report Apr 1, 2010 413
Miami Protest: AHF to Blast Merck on AIDS Drug Pricing During Barclays Investor Conference. Mar 23, 2010 1347
FDA announces possible safety concern for HIV drug combination. Brief article Mar 9, 2010 232
Warning added for didanosine. Mar 1, 2010 188
CA Pension Funds Express Concern Over Merck AIDS Drug Pricing, Says AHF. Mar 1, 2010 925
HIV drug given to protect foetus should be avoided after childbirth for 1yr. Feb 26, 2010 270
Increased HAART coverage tied to 50pc drop among injection drug users. Feb 22, 2010 238
Merck Rattled by AIDS Banners in Hometown. Feb 16, 2010 981
AHF: Merck's AIDS Drug Pricing Focus of S.F. Protest During Medical Conference at Moscone Center. Feb 16, 2010 1429
Hope for better AIDS drug soars. Feb 3, 2010 279
Breakthrough may lead to new HIV drugs. Feb 1, 2010 319
Fake healers--DA concerned. Bateman, Chris Brief article Feb 1, 2010 210
Merck Rewrites History on Pricing Top AIDS Drug, Isentress, Says AHF. Jan 21, 2010 1123
AHF Blasts Merck on AIDS Drug Pricing During Investor Conference Protest in S.F. Conference news Jan 11, 2010 670
Regional and temporal trends in migration among people living with HIV/AIDS in British Columbia, 1993-2005. Lima, Viviane D.; Druyts, Eric; Montaner, Julio S.G.; Hogg, Robert S. Report Jan 1, 2010 3479
Start anti-HIV drugs earlier, new federal guidelines say. Boschert, Sherry Clinical report Jan 1, 2010 605
Routine lab tests of toxic effects of HIV drugs can be safely scrapped: study. Dec 22, 2009 474
Don't Slash AIDS Drugs, CA Assembly Members Tell Governor. Dec 18, 2009 466
California's AIDS Drug Cuts 'Life or Death' for Patients. Dec 1, 2009 800
Johnson & Johnson's (New Brunswick NJ) Tibotec Therapeutics unit won approval for its Intelence HIV drug designed to treat patients who have stopped responding to other treatments. Brief article Nov 30, 2009 119
New HIV drug hope. Nov 30, 2009 91
Maternal HAART cuts postnatal HIV transmission risk. Nov 28, 2009 229
Concert Pharmaceuticals Initiates Phase 1b Clinical Trial of CTP-518, Protease Inhibitor for Treatment of HIV. Nov 9, 2009 740
Promising candidates for new HIV drugs found. Oct 21, 2009 321
New discovery may help create less toxic anti-HIV drugs. Oct 21, 2009 309
Promising candidates for new HIV drugs found. Oct 18, 2009 321
New discovery may help create less toxic anti-HIV drugs. Oct 18, 2009 309
FDA committee recommends wider use of Selzentry. Oct 13, 2009 632
Pfizer's Selzentry Poised To Be Most Expensive First-Line AIDS Drug. Oct 8, 2009 509
FDA Marks 100th HIV/AIDS Drug Authorized for Purchase Under PEPFAR. Oct 6, 2009 700
Avexa Closes ATC's Phase III Trial to Evaluate Data. Oct 2, 2009 547
NanoViricides, Inc. Signs a Master Service Agreement with Southern Research Institute for further Influenza and HIV Studies. Sep 21, 2009 1043
India says no to AIDS drug patents, reaffirms role as 'pharmacy' of poor countries. Sep 4, 2009 444
AHF Challenges Merck's "Criminal AIDS Drug Pricing" for Isentress. Sep 3, 2009 858
President Clinton, Pfizer, and Mylan Announce New Agreements to Lower Prices of Medicines for Patients with Drug-Resistant HIV in Developing Countries. Aug 6, 2009 1987
HAART may help reduce mother-to-child HIV transmission. Aug 2, 2009 252
AHF Renews Challenge to Merck on Price of AIDS Drug Isentress. Jul 24, 2009 806
ISENTRESSA (raltegravir), from MSD, was as Effective as Efavirenz at. Jul 22, 2009 819
Cavitation of the Ghon focus in an HIV-infected infant who acquired tuberculosis after the initiation of HAART. Innes, S.; Schaaf, H.S.; Cotton, M.F. Jun 22, 2009 1463
Africa must make own AIDS drugs. Bateman, Chris Brief article May 1, 2009 265
TWO pharmaceutical giants are to form; Business IN BRIEF. Apr 17, 2009 110
AIDS Activists Claim Victory: Abbott Cuts Mexican Price of Kaletra 20%. Mar 26, 2009 1061
HIV/TB: when is it safe to start HAART? Wood, Robin Mar 22, 2009 3251
Changes in body composition and other anthropometric measures of female subjects on Highly Active Antiretroviral Therapy (HAART): a pilot study in Kwazulu-Natal, South Africa. Esposito, F.M.; Coutsoudis, A.; Visser, J.; Kindra G. Clinical report Mar 22, 2009 4638
Avexa Reports Positive 96 Week Data for HIV Drug Apricitabine (ATC). Mar 16, 2009 918
Ramsell Public Health Rx Unveils AIDS Drug Assistance Program (ADAP) Data Management System. Feb 9, 2009 549
Research and Markets: Global HIV Market: New Analysis Discusses the Opportunities Prevailing in the HIV Drugs Market and Issues Affecting the Growth. Industry overview Feb 4, 2009 305
Gilead Sciences Inc (Foster City CA), the biggest supplier of AIDS drugs in the US, said fourth-quarter earnings rose 41% on increased demand for its medicines. Brief article Feb 2, 2009 268
Abbott Drug Pricing Condemned by AIDS Advocates in International Protests. Jan 28, 2009 1895
A cocktail for disaster: how mismanagement, slothful government and a tight state budget killed a pioneering AIDS fund for Illinois' black communities. Virella, Kelly Jan 1, 2009 3208
Good news in the fight against AIDS: from both medical and underwriting standpoints, HIV/AIDS has become a manageable disease. Hoehne, Brent; Swanson, Eric Dec 1, 2008 498
Maturation inhibitors as new antiretroviral agents. Richards, John; McCallister, Scott Clinical report Dec 1, 2008 3133

Terms of use | Copyright © 2013 Farlex, Inc. | Feedback | For webmasters | Submit articles